Brief: Bioporto Says Initiates Pivotal Clinical Study With The NGAL Test For Children

BioPorto A/S

02/10/2018 18:01

Oct 2 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * BIOPORTO INITIATES PIVOTAL CLINICAL STUDY WITH THE NGAL
TEST™
FOR CHILDREN   
    * STUDY WILL FORM BASIS FOR AN ADDITIONAL APPLICATION FOR
U.S. FDA
REGULATORY CLEARANCE OF NGAL TEST
    * SAYS EXPECTS TO SUBMIT AN APPLICATION TO FDA IN FIRST HALF
OF
2019

Source text for Eikon:  ID:nGNE24NZgP 
Further company coverage:  BIOPOR.CO 

 ((Reuters.Briefs@thomsonreuters.com;))